Kemble George
- SEC CIK
- 0001858176
In the past year, 4 open-market sale filings worth $4.22M and no purchases.
Current role at each company
- SGMT Sagimet Biosciences Inc.Directoras of Aug 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.22M
- 4 filings
- Net
- −$4.22M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kemble George as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:05 PM ET | Aug 14 | 3 days | Kemble GeorgeDirector | SSaleSeries A Common Stock | −351.0K | $10.23 | −$3.59M | −85.0%62.2K after | 10b5-1 |
| Aug 12, 2026 (view filing)7:41 PM ET | Aug 11 | 1 day | Kemble GeorgeDirector | SSaleSeries A Common Stock | −20.2K | $9.95 | −$201.1K | −24.5%62.2K after | 10b5-1 |
| Jul 22, 2026 (view filing)4:05 PM ET | Jul 20 | 2 days | Kemble GeorgeDirector | SSaleSeries A Common Stock | −18.8K | $7.46 | −$140.5K | −23.3%62.2K after | 10b5-1 |
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Kemble GeorgeExecutive Chairman | SSaleSeries A Common Stock | −37.7K | $7.69 | −$289.8K | −31.8%81.0K after | 10b5-1 |
| Jul 25, 2024 (view filing) | Jul 23 | 2 days | Kemble GeorgeExecutive Chairman | SSaleSeries A Common Stock | −23.6K | $3.17 | −$74.9K | −16.6%118.7K after | 10b5-1 |
| Jul 23, 2024 (view filing) | Jul 19 | 4 days | Kemble GeorgeExecutive Chairman | SSaleSeries A Common Stock | −14.1K | $3.10 | −$43.6K | −9.0%142.3K after |